Skip to content

Clinical study on the anesthetic effect of oxycodone on gynecological day hysteroscopic surgery

Clinical study on the anesthetic effect of oxycodone on gynecological day hysteroscopic surgery

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300078799
Enrollment
Unknown
Registered
2023-12-19
Start date
2023-12-20
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial polyp,Uterine myoma

Interventions

Experimental group:Midazolam 0.04mg/kg intravenously, oxycodone 0.2mg/kg intravenously, propofol 1-2 mg/kg intravenously for anesthesia induction, laryngeal mask was inserted, and propofol 3-5mg/kg/h
Control group:Midazolam 0.04mg/kg intravenously, Sufentanil 0.2ug/kg intravenously, propofol 1 ~ 2 mg/kg intravenously for anesthesia induction, laryngeal mask was inserted, and propofol 3-5mg/kg/h pu

Sponsors

Weifang maternal and child health care hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 59 Years

Inclusion criteria

Inclusion criteria: 1.Patients with indications for daytime hysteroscopic surgery; 2.Age = 18 years old, under 60 years old; 3.BMI:18.5-27.9kg/m2; 4.ASA:?~?.

Exclusion criteria

Exclusion criteria: 1.Patients with drug allergy used in this experiment; 2.Patients with long operation time and heavy intraoperative bleeding; 3.People with mental illness; 4.A history of chronic pain and opioid dependence.

Design outcomes

Primary

MeasureTime frame
VAS;

Secondary

MeasureTime frame
MAP, HR, SpO2 and BIS values were obtained before anesthesia, after injection, after implantation of laryngeal mask, 5min, 10min after operation and when laryngeal mask was removed;Incidence of adverse reactions (hypotension, nausea and vomiting, dizziness and headache, etc.);Recovery time;Exit time;

Countries

China

Contacts

Public ContactFan Bo

Weifang Maternal and Child Health Hospital

850921582@qq.com+86 187 6569 2653

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026